Medical director contracting.

Those nephrologists who are entering into new, or re-negotiating old, medical director contracts should take into consideration the large number of changes in the environment that have a bearing on the structure and wording of proposed contracts. This contribution offers specific guidance to assist with those efforts.

Nephrogenic systemic fibrosis and gadolinium-based contrast: medico-legal implications.

The epidemiologic link between exposure to gadolinium-based contrast (GBC) agents and the development of nephrogenic systemic fibrosis (NSF) in patients with moderate to severe end-stage renal disease (ESRD) has caused concern among physicians, particularly radiologists and nephrologists. The concerns of manufacturers of GBC agents and the U.S.

Dialysis facility joint ventures--current structures and issues.

With the ongoing consolidation of the health care industry, including renal care, providers and physicians alike are using joint ventures as a means to partner on business transactions. This article discusses the expanding use of joint ventures in health care, including the dialysis industry, and looks at the types of structures being utilized and key legal concerns relating to such structures and issues.